Compounded Semaglutide – Phase 2 – One month supply

Description

IMPORTANT: This is a compounded medication prepared by a licensed pharmacy. It is NOT FDA-approved and has not been reviewed by the FDA for safety, efficacy, or quality. This is not the same as FDA-approved semaglutide products (Ozempic®/Wegovy®/Rybelsus®).

Description
What is Compounded Semaglutide?

Compounded Semaglutide is a customized formulation prescribed by healthcare providers for patients seeking support with weight management as part of a comprehensive program including diet and exercise.

Semaglutide is a GLP-1 receptor agonist that works by mimicking natural hormones that affect appetite and satiety. This compounded version is prepared according to your provider’s prescription when commercially available options may not meet your individual needs.

How It Works

Semaglutide:
* May help regulate appetite and feelings of fullness
* May support metabolic processes
* Works through GLP-1 receptor pathways

Results vary significantly between individuals. This medication should be used only as part of a supervised weight management program including diet and exercise. Weight loss is not guaranteed.

How to Use

Administered as a once-weekly subcutaneous injection. Your healthcare provider will determine the appropriate dosage based on your individual needs and response to treatment.

Potential Side Effects

Common side effects may include:
* Nausea
* Vomiting
* Diarrhea
* Decreased appetite
* Stomach discomfort
* Constipation
* Injection site reactions

These side effects often improve as your body adjusts. Contact your healthcare provider if side effects persist or worsen.

Serious side effects are possible. Seek immediate medical attention if you experience:
* Severe abdominal pain
* Vision changes
* Signs of pancreatitis
* Severe allergic reactions
* Signs of thyroid tumors (lump in neck, difficulty swallowing, hoarseness)

Important Safety Information

⚠️ **Do not use if you have:**
* Personal or family history of medullary thyroid carcinoma (MTC)
* Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
* Known hypersensitivity to semaglutide or any ingredients
* History of severe gastrointestinal disease

**Other important information:**
* Use only under healthcare provider supervision
* Not a substitute for diet and exercise
* Individual results vary – weight loss is not guaranteed
* This compounded formulation has not undergone FDA review
* May interact with other medications – inform your provider of all medications you take
* Not recommended during pregnancy or breastfeeding

About Compounding

This medication is prepared by a licensed compounding pharmacy according to your provider’s prescription. Compounded medications:
* Are NOT FDA-approved
* Have not undergone FDA review for safety or effectiveness
* May differ in strength, quality, and purity from FDA-approved products
* Are prescribed when commercially available options may not meet individual patient needs